Guideline on shared facilities coming into effect 01 June 2015

 

 

 

  • December 1st 2015 : For medicinal products introduced for the first time into shared manufacturing facilities.

  • June 1st 2016 : For manufacturers of products for human use already produced in shared manufacturing facilities (unless existing arrangements scientiffically justified) including those who manufacture human and veterinary medicines using shared manufacturing facilities.

  • June 1st 2017 : For manufacturers solely producing products for veterinary use (unless existing arrangements scientiffically justified) .

To fullfill guideline on shared facilities requirements within the deadlines imposed, we elaborate some customized PDE monographs for all products concerned. Access directly to our database which contains more than 1,000 PDEs already developed.

Latest news

Back to physical CPhI 2021

SOCOSUR WILL BE BACK TO CPHI WITH BOOTH LOCATED 14B61   CPhI Worldwide houses six...(...)

A3P Cosmetics Symposium 2021

Back to face to face events for Socosur. We will attend A3P Cosmetics symposium 2021 with a...(...)

A3P Cleaning Validation Symposium

Next June 29th and 30th 2021, Socosur Tox will exhibit at the second edition of the A3P Cleaning...(...)

HydroxyChloroquine Sulfate free of charge PDE and OEL monographs to support the fight versus Covid-19

As responsible player in the European healthcare system, we have organized ourselves to meet our...(...)

Stay in touch

Contact us